Submit your research
Start your submission and get more impact for your research by publishing with us.
- Frontiers in Pharmacology
- Drugs Outcomes Research and Policies
Explores the interactions between chemicals and living beings
Explores the evaluation of drugs, advanced therapies and medical devices containing drugs in real life conditions, following their approval by regulatory authorities and access to the market.
Author guidelines
Ready to publish? Check out our author guidelines for everything you need to know about submission, from choosing a journal and section to preparing your manuscript.
Editor guidelines
Reviewing a manuscript? See our editorial guidelines for everything you need to know about Frontiers’ peer review process.
Peer review
Our efficient and rigorous peer review means you’ll get a decision on your manuscript in just 77 days.
Publishing fees
Article processing charges (APCs) apply to articles that are accepted for publication by our external editors, following rigorous peer review.
Editors
See all- BR
bernd rosenkranz
Fundisa African Academy of Medicines Development
Cape Town, South Africa
Specialty Chief Editor
Drugs Outcomes Research and Policies
- MH
mohd hafiz abdul-aziz
The University of Queensland
Brisbane, Australia
Associate Editor
Drugs Outcomes Research and Policies
- FA
filipa alves da costa
Faculty of Pharmacy, University of Lisbon
Lisbon, Portugal
Associate Editor
Drugs Outcomes Research and Policies
- AA
anthony attama
University of Nigeria, Nsukka
Nsukka, Nigeria
Associate Editor
Drugs Outcomes Research and Policies
Articles
See all (2,039)Original Research
Published on 03 Apr 2025
Anticoagulation quality with warfarin therapy, and associated factors among adult outpatients at public hospitals in nekemte town, western Ethiopia: a retrospective study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacologydoi 10.3389/fphar.2025.1544957Original Research
Published on 03 Apr 2025
Argatroban in patients with acute ischemic stroke with early neurological deterioration: a cost-effectiveness analysis from the perspective of Chinese healthcare system
in Drugs Outcomes Research and Policies
Frontiers in Pharmacologydoi 10.3389/fphar.2025.1470373Original Research
Published on 02 Apr 2025
Development and validation of a Chinese insulin medication literacy scale for patients with diabetes mellitus
in Drugs Outcomes Research and Policies
Frontiers in Pharmacologydoi 10.3389/fphar.2025.1477050- 227 views
Original Research
Published on 02 Apr 2025
Overall compilation of adverse effects of non-steroidal anti-inflammatory drugs: a hypothesis-free systematic investigation using a nationwide cohort study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacologydoi 10.3389/fphar.2025.1539328- 158 views
Research Topics
See all (94)Submission open
Exploring the Applications of Artificial Intelligence in Disease Screening, Diagnosis, Treatment, and Nursing
- Zhijia Xia
- Jin Bin
- YaXuan Wang
- Lisa Jia Tran
- 775 views
Submission open
Cannabidiol: Perspectives on Drug-Resistant Epilepsy Management
- Alberto Lazarowski
- Dolores E López García
- Jerónimo Andrés Auzmendi
- Antonio Gil-Nagel
- 442 views
Submission open
Increasing Importance of Patients-generated Real World Data for Healthcare Policy Decisions about Medicinal Products: Volume III
- Kenneth KC Lee
- Paul Scuffham
- Shu Chuen Li
- David Bin-Chia Wu
- Jeff Guo
- 779 views
Submission open
Environmental Impact of Medicines
- Jerin Jose Cherian
- Thamir M Alshammari
- Ryan Walker
- William Sander
- Laxmi Govindraj
- 964 views